The industry might be asking why would the Department conduct the review after its interpretation of the criteria has already changed? Individual companies might be asking why the new interpretation has not applied to their requests? …
Latest Video
New Stories
-
New partnership expands access to care for Australians with rare cancers
May 19, 2026 - - Latest News -
Sandoz urges faster access as government signals biosimilar consultation
May 19, 2026 - - Latest News -
Perth hosts AusMedtech conference as industry focuses on innovation and commercialisation
May 19, 2026 - - Latest News -
Government sidesteps committee call on CGMs, insulin pumps and GLP‑1 access
May 18, 2026 - - Latest News -
Budget papers signal the work that has already been done on reform proposals
May 18, 2026 - - Latest News -
If the demand is to pay for reform, are these reforms really worth paying for?
May 18, 2026 - - Latest News -
The 'Dispatched' Week in Review' Podcast - 15 May
May 15, 2026 - - Podcast